CRH and irritable bowel syndrome: Fukudo et al. (1998) observed that the intravenous injection of CRF in IBS patients induced exaggerated motility of the colon and increased visceral pain sensitivity compared with healthy controls, whereas administration of a non-selective CRF receptor antagonist ameliorated these responses (Lembo et al., 1996; Sagami et al., 2004).